- Home
- TOUR vs OPTN Comparison
TOUR vs OPTN Comparison
Compare TOUR & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOUR
- OPTN
- Stock Information
- Founded
- TOUR 2006
- OPTN 2010
- Country
- TOUR China
- OPTN United States
- Employees
- TOUR N/A
- OPTN N/A
- Industry
- TOUR Transportation Services
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- TOUR Consumer Discretionary
- OPTN Health Care
- Exchange
- TOUR Nasdaq
- OPTN Nasdaq
- Market Cap
- TOUR 101.0M
- OPTN 92.8M
- IPO Year
- TOUR 2014
- OPTN 2017
- Fundamental
- Price
- TOUR $0.97
- OPTN $9.39
- Analyst Decision
- TOUR
- OPTN Hold
- Analyst Count
- TOUR 0
- OPTN 3
- Target Price
- TOUR N/A
- OPTN $9.00
- AVG Volume (30 Days)
- TOUR 102.2K
- OPTN 41.7K
- Earning Date
- TOUR 06-03-2025
- OPTN 05-20-2025
- Dividend Yield
- TOUR 3.81%
- OPTN N/A
- EPS Growth
- TOUR N/A
- OPTN N/A
- EPS
- TOUR 0.09
- OPTN N/A
- Revenue
- TOUR $70,367,853.00
- OPTN $78,226,000.00
- Revenue This Year
- TOUR $16.99
- OPTN $30.49
- Revenue Next Year
- TOUR $13.23
- OPTN $13.51
- P/E Ratio
- TOUR $10.94
- OPTN N/A
- Revenue Growth
- TOUR 16.40
- OPTN 10.20
- 52 Week Low
- TOUR $0.71
- OPTN $4.82
- 52 Week High
- TOUR $1.76
- OPTN $20.03
- Technical
- Relative Strength Index (RSI)
- TOUR 52.37
- OPTN 76.15
- Support Level
- TOUR $0.90
- OPTN $9.14
- Resistance Level
- TOUR $0.98
- OPTN $9.45
- Average True Range (ATR)
- TOUR 0.04
- OPTN 0.08
- MACD
- TOUR 0.01
- OPTN -0.07
- Stochastic Oscillator
- TOUR 75.08
- OPTN 80.71
About TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.